Mar 5, 2024

News Roundup - February 2024

Article Summaries

Light Blue
By Matthew Xia

Our faculty members frequently make appearances in the media as expert consultants or authors. This article summarizes the faculty media appearances that were featured in our Department newsletter in February 2024.

Misunderstanding of mental illness clouds MAID expansion, patient and psychiatrist say 

CBC News. February 1, 2024. Featuring Dr. Madeline Li.

Dr. Li emphasizes the need for more specific legislation regarding medical assistance in dying (MAID) for mental disorders, advocating for a deeper understanding of patients' requests and cautioning against factors like lack of access to mental health care influencing their decision.

Where to go next with assisted dying in Canada. 

The Toronto Star. February 3, 2024. By Dr. Sonu Gaind.

Dr. Gaind reflects on the ethical complexities surrounding medical assistance in dying (MAID) for mental illness in Canada, emphasizing the need for thoughtful policy development and increased resources for mental health care rather than quick fixes.

CAMH psychiatrist wows on Jeopardy and heads to Tournament of Champions 

CBC News: The Current. February 5, 2024. Featuring Dr. Juveria Zaheer.

Dr. Zaheer from Whitby secured her victory in the Jeopardy Wildcard Tournament, claiming a prize of 100 thousand U.S. dollars and advancing to the Tournament of Champions.

The Potential of Ketamine in Mood Disorders – An Interview with Dr. Joshua Rosenblat 

IMS Magazine. February 7, 2024. Featuring Dr. Joshua Rosenblat.

Dr. Rosenblat, working at the Mood Disorders Psychopharmacology Unit at Toronto Western Hospital, specializes in treating severe cases of major depressive disorder and bipolar disorder, focusing on patients with treatment-resistant depression and researching innovative treatments like ketamine and psilocybin.

Gut Signature for Treatment-Resistant Schizophrenia? 

MedScape. February 7, 2024. Featuring Dr. Roger McIntyre.

Dr. McIntyre highlighted the study as "interesting and rigorous," offering preliminary evidence of a distinct gut microbiome diversity in treatment-resistant schizophrenia patients, potentially due to medication effects, but emphasized the need for further research.

More Adolescent Boys Have Eating Disorders. Two Experts Discuss Why. 

New York Times. February 8, 2024. Featuring Dr. Sarah Smith.

Dr. Smith discusses the expanded scientific understanding of eating disorders and their increasing prevalence among boys and men.

Increasing MAiD Rates in Canada 

Global Radio. February 8, 2024. Featuring Dr. Sonu Gaind.

Dr. Gaind expressed concerns about the increase in medically assisted deaths in Canada and the minimal attention given to those whose natural deaths were not reasonably foreseeable, emphasizing the lack of data on equity and diversity and the implications of expanding MAID eligibility to individuals with mental illness.

First clinical guidelines to address anxiety in older adults 

Hospital News. February 9, 2024. Featuring Dr. Andrea Iaboni.

Dr. Iaboni, alongside a team of experts and with the support of the Canadian Coalition for Seniors Mental Health, developed the first-ever clinical guidelines for managing anxiety in older Canadians, providing health care providers with essential tools and resources for better supporting this demographic.

Limits Placed By Ozempic Raise Concern 

Nigerian Canadian News. February 10, 2024. Featuring Dr. Sanjeev Sockalingam.

Dr. Sockalingam warns that limiting access to Ozempic for weight-loss treatment could exacerbate health inequities, especially among those who cannot afford private care, increasing their vulnerability to obesity and related health risks.

Can Ozempic treat depression? Early signs point to yes 

MedicalXPress. February 19, 2024. Featuring Dr. Rodrigo Mansur.

Dr. Mansur is involved in a study exploring the potential mental health benefits of GLP-1 medications like Wegovy and Zepbound on cognitive symptoms associated with depression, highlighting the intricate connections between metabolism, mood, and cognitive functions.

Competing in the Tournament of Champions on Jeopardy! 

Newstalk1010. February 20, 2024. Featuring Dr. Juveria Zaheer.

Dr. Zaheer won the Group One Champions Wildcard tournament on Jeopardy!, securing a spot in the Tournament of Champions with a grand prize of $100,000.

Refractory schizophrenia may be associated with a specific profile of intestinal microbiota, says study 

(Portuguese) - MedScape. February 21, 2024. Featuring Dr. Roger McIntyre.

Dr. McIntyre's research reveals that adult patients with refractory schizophrenia have distinct gut microbiome profiles compared to those who respond to treatment, a phenomenon potentially linked to clozapine use, highlighting the need for further studies to explore therapeutic strategies involving the microbiome.

Rise of sexual assaults cases in the sports industry 

News Talk Saskatoon 650. February 21, 2024. Featuring Dr. Ariel Dalfen.

Dr. Dalfen emphasizes the importance of discussing and addressing physical and sexual assault with children, especially in the context of hockey, to ensure they understand it's never acceptable and to create a culture of safety and speaking up within the sport.

Alumni Profile: Jeopardy! Champ Juveria Zaheer on Second Chances at Success 

Temerty Medicine News. February 21, 2024. Featuring Dr. Juveria Zaheer.

Dr. Zaheer, a notable psychiatrist and researcher at CAMH and the University of Toronto, who specializes in suicide risk assessment and prevention, has also gained recognition for her trivia expertise by advancing to Jeopardy!’s Tournament of Champions after winning a Wildcard tournament.

Canada’s assisted dying laws in spotlight as expansion paused again 

The Guardian. February 25, 2024. Featuring Dr. Sonu Gaind.

Dr. Gaind raises concerns over the expansion of Canada's medically assisted dying laws.

Palliative Psychiatry May Ease Suffering, Protect Against Futile Treatments 

Psychiatric News. February 27, 2024. Featuring Dr. Sarah Levitt.

Dr. Levitt emphasizes the importance of a palliative care approach in psychiatry, focusing on alleviating suffering and enhancing quality of life for patients with serious and enduring mental illnesses, advocating for collaborative decision-making and ethical considerations.